Stockreport

Genmab to purchase US-based biotech company ProfoundBio for $1.8 billion in all-cash deal [Seeking Alpha]

Genmab A/S - American Depositary Shares  (GMAB) 
PDF ProfoundBio is headquartered in Seattle, Washington, with an R&D center of innovation in Suzhou, China, and has developed a pipeline consisting of multiple ADC drug can [Read more]